Company news

Share this article:

Amgen said on Monday that 2,200 employees would lose their jobs under a company restructuring that includes about 675 layoffs at its headquarters in Thousand Oaks, CA, The Ventura County Star reported.

The total number of job cuts was close to what the company estimated when it announced in August that 2,200 to 2,600 job cuts were needed as part of a plan to reduce costs.  Amgen has seen decreased revenue during 2007 from its main anemia drug, Aranesp, after studies that raised safety concerns about anemia drugs and changes in how Medicare pays for them.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.